Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
02/2000
02/16/2000EP0979295A1 Expression of fungicide-binding polypeptides in plants for producing fungicide tolerance
02/16/2000EP0979294A2 Gene conversion as a tool for the construction of recombinant industrial filamentous fungi
02/16/2000EP0979293A1 Transcriptional silencing elements and their binding factors
02/16/2000EP0979292A2 Gene construct encoding a heterologous prodrug-activating enzyme and a cell targeting moiety
02/16/2000EP0979291A1 Methods of production of an amidated peptide through the use of a fusion protein
02/16/2000EP0979290A2 Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors
02/16/2000EP0979289A1 Human lysophospholipase
02/16/2000EP0979288A2 Diagnosis and treatment of phosphatase- or kinase-related disorders
02/16/2000EP0979287A2 Production of ascorbic acid in plants
02/16/2000EP0979286A2 Combinatorial polyketide libraries produced using a modular pks gene cluster as scaffold
02/16/2000EP0979285A1 Methods to detect granulocytic ehrlichiosis
02/16/2000EP0979284A2 Methods and reagents for vaccination which generate a cd8 t cell immune response
02/16/2000EP0979283A2 Genes controlling floral development and apical dominance in plants
02/16/2000EP0979282A1 Rat st38.2 chemokine
02/16/2000EP0979281A2 A method for making multispecific antibodies having heteromultimeric and common components
02/16/2000EP0979280A1 Polynucleotides encoding a cd53-like transmembrane protein
02/16/2000EP0979279A2 Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging
02/16/2000EP0979278A1 Methods for detecting and reversing resistance to macrocyclic lactone compounds
02/16/2000EP0979277A1 Novel human tumour suppressor gene
02/16/2000EP0979276A1 Complement receptor type 1 (cr1)-like sequences
02/16/2000EP0979275A1 Novel human mago nashi protein
02/16/2000EP0979274A2 Human p24 vesicle proteins
02/16/2000EP0979273A1 MODIFIED ANTISENSE NUCLEOTIDES COMPLEMENTARY TO A SECTION OF THE HUMAN Ha-Ras GENE
02/16/2000EP0979271A1 Vascular adhesion protein-1 having amine oxidase activity
02/16/2000EP0979246A2 Man monoclonal antibodies to epidermal growth factor receptor
02/16/2000EP0979239A1 Prevention and treatment of hepatocellular cancer
02/16/2000EP0979235A1 Isolated nucleic acid molecule coding for tumor rejection antigen precursors mage-c1 and mage-c2 and uses thereof
02/16/2000EP0979106A1 Use of a modified baculovirus containing exogenous nucleic acid for the manufacture of a medicament for delivering said nucleic acid to the hepatocytes
02/16/2000EP0979102A1 Polyalkylene oxide-modified single chain polypeptides
02/16/2000EP0979101A1 Recombinant canine adenovirus (cav) containing exogenous dna
02/16/2000EP0979094A2 Agent for enhancing the heart force
02/16/2000EP0979093A1 Arrestable therapeutic viral agent
02/16/2000EP0979088A1 Method of inducing vasodilation and treating pulmonary hypertension using adenoviral-mediated transfer of the nitric oxide synthase gene
02/16/2000EP0979080A1 A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent
02/16/2000EP0667918B1 Non-radioactive hybridization assay and kit
02/16/2000EP0561885B1 Subunit papillomavirus vaccine
02/16/2000CN1244921A Treatment and diagnosis of cancer
02/16/2000CN1244896A Non-M, non-O, HIV-1 strains, fragments and applications
02/16/2000CN1244895A Carrot anti-freeze polypeptides
02/16/2000CN1244894A Tissue type plasminogen activator (t-PA) variants: compositions and methods of use
02/16/2000CN1244873A Antibodies that bind to the nidogen-binding domain of laminin, their production and use
02/16/2000CN1244871A H. pylori antigens
02/16/2000CN1244870A Tissue specific expression of retinoblastoma protein
02/16/2000CN1244860A Cyclic imines as pesticides
02/16/2000CN1244807A Improved vacines
02/16/2000CN1244803A Soluble CTLA4 mutant molecules and uses thereof
02/16/2000CN1244772A Targeted cytotoxic cell
02/16/2000CN1244769A Antimicrobial proteins
02/16/2000CN1244585A Method for leading-in petunia transcription factor Pet SPL 2 gene to shorten inflorescence internode
02/16/2000CN1244584A Chemotarix factor with immunocyte chemotaxis and hemopoinesis stimulating activity
02/16/2000CN1244583A Preparation and application of native swine vescular disease virus strain and its variant strain
02/16/2000CN1244536A Angiogenesis inhibiting factor 1 and its derivative and application
02/16/2000CN1049454C Method for producing transgenic corn plants
02/15/2000US6025546 Method to obtain male sterile plants
02/15/2000US6025545 Reproducible system for the production of stable, genetically transformed maize cells, and to methods of selecting cells that have been transformed
02/15/2000US6025544 Use of dna molecules encoding sucrose carriers for modifying plant flowering behavior
02/15/2000US6025543 Seed plants exhibiting early reproductive development and methods of making same
02/15/2000US6025542 Method for obtaining transgenic plants showing a modified fructan pattern
02/15/2000US6025541 Isolated non-coding nucleotide sequences useful as promoters for heterologous gene expression in plants
02/15/2000US6025540 Transgenic non-human mammal comprising a dna sequence encoding human extracellular superoxide dismutase (human ec-sod) or a variant thereof which is expressed in the milk
02/15/2000US6025539 IL-5 transgenic mouse
02/15/2000US6025505 Fluorescent labeling probes for immunoassays, dna sequencing, detecting products of polymerase chain reactions
02/15/2000US6025485 Methods and compositions for peptide libraries displayed on light-emitting scaffolds
02/15/2000US6025484 Protein D--an IgD-binding protein ofhaemophilus influenzae
02/15/2000US6025483 Maize and cauliflower apetalai gene products and nucleic acid molecules encoding same
02/15/2000US6025476 Method of detecting fibrinogen; diagnostic methods for determining information associated with atherogenesis and/or thrombogenesis, as well as for determining information associated with pregnancy status or outcome
02/15/2000US6025474 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof
02/15/2000US6025473 Nucleic acid which encodes a protein which can confer multidrug resistance on a drug sensitive mammalian cell when expressed in the cell and which is overexpressed in certain multidrug resistant cancer cell lines
02/15/2000US6025469 Murine UCP3 polypeptides
02/15/2000US6025467 Parathyroid hormone derivatives and their use
02/15/2000US6025465 Insulin-like growth factor binding protein (IGFBP-6)
02/15/2000US6025342 Analog of Haemophilus Hin47 with reduced protease activity
02/15/2000US6025341 Chimeric hepatitis B/hepatitis C virus vaccine
02/15/2000US6025340 Surface expression of enzyme in gene directed prodrug therapy
02/15/2000US6025339 Oligo is antisense to the initiation codon, the coding region or the 5' and 3' intronexon junctions of a gene encoding the adenosine a.sub.1 receptor or antisense to an adenosine a.sub.1 receptor mrna; and
02/15/2000US6025337 Solid microparticles for gene delivery
02/15/2000US6025325 Pegylated obese (ob) protein compositions
02/15/2000US6025204 Diagnostic method for detection of placental-derived prostate growth factors
02/15/2000US6025198 Antisense modulation of Ship-2 expression
02/15/2000US6025197 Secreted salivary zsig32 polypeptides
02/15/2000US6025196 Chimeric proteins comprising liver enriched transcription factors and nucleic acids encoding the same
02/15/2000US6025195 Liver-specific adenovirus expression vector
02/15/2000US6025193 Dna construct of promoter, antisense oligonucleotide which binds to messenger rna in the translational start site region encoding the receptor, and a polyadenylation signal sequence; for improved selectivity in treatment
02/15/2000US6025192 Modified retroviral vectors
02/15/2000US6025191 For diagnosis, immunotherapy, gene therapy and anticarcinogenic agents
02/15/2000US6025190 Temperature-sensitive plasmid
02/15/2000US6025188 Degrading a mycotoxin having a tricabyllic ester by contacting with an esterase enzyme; for treating grain, silage, food crops and animal feed
02/15/2000US6025185 Fungus wherein the areA gene has been modified and an areA gene from Aspergillus oryzae
02/15/2000US6025184 Cosmid contained in atcc 69789 comprising a dna fragment isolated from klebsiella pneumoniae which encodes an active glycerol dehydratase; for efficient production
02/15/2000US6025183 Recombinant expression vector of a dna sequence encoding human acetylcholinesterase and a human promoter; for screening assays to test treatments for alzheimer's disease, retinal photoreceptor degeneration, hematopoietic disorders
02/15/2000US6025181 Equine herpesvirus-4TK mutant
02/15/2000US6025180 Asp1
02/15/2000US6025179 Method for cloning and producing the SnaBI restriction endonuclease and purification of the recombinant SnaBI restriction endonuclease
02/15/2000US6025176 For diagnosis and monitoring of insulin dependent diabetes mellitis; antidiabetic agents
02/15/2000US6025175 Amino acid sequence; for screening new bactericides and bacteristats to treat otitis media, conjunctivitis, pneumonia, bacteremia, meningitis, sinusitis, pleural empyema and endocarditis; diagnosis of infections
02/15/2000US6025174 Amino acid sequence; for production of new antibiotics by derivatizing vancomycin glycopeptides
02/15/2000US6025172 Amino acid sequence of the delta-12-desaturase enzyme; for reducing autooxidation by changing fatty acid composition in the kernel oil of hazelnuts for reduced spoilage
02/15/2000US6025167 RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
02/15/2000US6025166 Human trk receptors and neurotrophic factor inhibitors
02/15/2000US6025164 Bacterial antigens and vaccine compositions